Skip to main content
. 2019 May 24;9:437. doi: 10.3389/fonc.2019.00437

Table 5.

Changes in serum levels of ceruloplasmin, copper, and iron, urine levels of copper and zinc related to treatment response.

PD (n = 9) SD ≥ 4 M/PR/CR (n = 7) p-value
Serum Ceruloplasmin (mg/dL)
  Baseline 45.25 (17.96) 42.44 (15.11) 1.000
  After one cycle 46.76 (17.97) 36.25 (6.72) 0.315
  After three cycle 49.10 (12.31) 33.47 (5.90) 0.100
  Nadir 41.26 (15.78) 38.23 (16.90) 0.385
Serum Copper (μg/dL)
  Baseline 143.50 (68.99) 131.57 (41.84) 0.862
  After one cycle 152.60 (41.74) 109.33 (28.25) 0.120
  After three cycle 157.20 (40.07) 93.50 (26.04) 0.022
  Nadir 128.50 (40.25) 106.43 (42.63) 0.247
Serum Iron (μg/dL)
  Baseline 35.50 (16.69) 62.83 (22.09) 0.030
  After one cycle 49.80 (18.13) 64.00 (16.16) 0.234
  After three cycle 55.75 (12.74) 60.00 (16.54) 1.000
  Nadir 35.50 (16.69) 52.50 (15.54) 0.090
Urine Copper
  Baseline (μg/dL) 2.55 (2.74) 2.94 (2.82) 0.561
  Day 14 (24 h) (μg) 83.74 (12.44) 94.22 (59.78) 1.000
  Day 64 (24 h) (μg) 128.80 (–) 158.53 (129.56) 1.000
Urine Zinc
  Baseline (μg/dL) 49.70 (41.74) 55.07 (76.73) 0.654
  Day 14 (24 h) (μg) 949.32 (896.66) 993.45 (379.33) 0.518
  Day 64 (24 h) (μg) 910.00 (–) 1163.79 (929.82) 1.000

Data was presented as mean (SD) and data was analyzed by Mann-Whitney U-test. CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease.